mw189
Small moleculeexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2017 (NCT02942771)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mw189
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05020535 | Phase 2 | Jan 15, 2022 | Johns Hopkins University, National Institute on Aging (NIA), University of Kentucky |
| NCT02942771 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2017 | Alzheimer's Association, Duke University, University of Kentucky |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Kentucky | Academic/Hospital | 2 | 1 | 1 | 2017 |
| Alzheimer's Association | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Duke University | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Johns Hopkins University | Academic/Hospital | 1 | 1 | 1 | 2022 |
| National Institute on Aging (NIA) | Government | 1 | 0 | 1 | 2022 |
5 organizations
Page 1 / 1